#

19-21 SEPTEMBER 2017 //

 BERLIN, GERMANY

Speakers

Loading
Niranjan Sardesai

Dr Niranjan Sardesai

Chief Operating Officer, Inovio Pharmaceuticals

Dr. Sardesai has broad development and consulting experience in biotechnology and pharmaceuticals, and in particular vaccine product development.  He served as Sr. Vice President, Research & Development at Inovio Pharmaceuticals before being promoted to his current position as Inovio’s Chief Operating Officer.  Dr. Sardesai is responsible for leading the company’s corporate development function and product development programs in infectious disease and cancer vaccines and vaccine delivery systems.  Programs under his leadership include candidate infectious disease vaccines for HIV, HPV, ebola, influenza, dengue, chikungunya, malaria, HBV, and HCV and cancer vaccines for cervical and prostate cancer.  He currently serves as the PI on a DARPA funded program for development of ebola vaccines and monoclonals, NIAID funded HVDDT contract and an IPCAVD grant for the development of HIV vaccines, and co-PI on a PA-CURE grant for the development of HCV vaccines.  Prior to VGX, Dr. Sardesai was the Founder and President of NVision Consulting Inc., a strategy consulting firm focused on entrepreneurial companies in the biopharma /lifesciences industry, and he served as Director R&D at Fujirebio Diagnostics, Inc. At FDI, Dr. Sardesai oversaw all aspects of R&D activities and expansion of the oncology portfolio. Products developed under his leadership include new-to-the-world tests for mesothelioma (MESOMARK™), bladder cancer and a multi-marker test for ovarian cancer. Dr. Sardesai also served as Senior Scientist at IGEN International, Inc., where his group helped develop a high-throughput screening platform for drug-discovery.

 

Dr. Sardesai has authored over 100+ peer-reviewed manuscripts and book chapters, delivered over 120+ invited talks and presentations, and filed several patents. He received a Ph.D. in Chemistry from the California Institute of Technology and an MBA from the Wharton School of the University of Pennsylvania, where he was the recipient of the Shils-Zeidman Award in Entrepreneurship. He was awarded fellowships at Scripps Research Institute and Massachusetts Institute of Technology. Dr. Sardesai received his bachelors and masters in Chemistry from the Indian Institute of Technology, Mumbai.  Dr. Sardesai was recently recognized by Pharmavoice magazine as one of the top 100 most influential and inspirational leaders from across the life sciences and healthcare industry (2015).  He lives in Blue Bell, PA with his wife and their two sons they are raising to be responsible global citizens.

Sessions

2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad

Sponsors

  • #
  • #
  • #
  • #
  • TrakCel, Silver Sponsor at Cell & Gene Therapy Europe
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #